Effect of Levosimendan on Ventricular Arrhythmias and Prognostic Autonomic Indexes in Patients With Decompensated Advanced Heart Failure Secondary to Ischemic or Dilated Cardiomyopathy-Reference-Cited by-同舟云学术

Effect of Levosimendan on Ventricular Arrhythmias and Prognostic Autonomic Indexes in Patients With Decompensated Advanced Heart Failure Secondary to Ischemic or Dilated Cardiomyopathy

Published:2006-12 Issue:12 Volume:98 Page:1641-1645
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Flevari Panayota,Parissis John T.,Leftheriotis Dionyssios,Panou Fotis,Kourea Kallirrhoe,Kremastinos Dimitrios Th.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure;Kivikko;J Clin Pharmacol,2002

2. Levosimendan: implications for clinicians;Mc Bride;J Clin Pharmacol,2003

3. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure;Parissis;Am J Cardiol,2005

4. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure;Parissis;Am J Cardiol,2004

5. Effects of levosimendan on cardiac arrhythmia: electrophysiologic and ambulatory electrocardiographic findings in phase II and III clinical studies in cardiac failure;Singh;Am J Cardiol,1999

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pilot study of the proarrhythmic effects of pimobendan injection in clinically healthy cats;Veterinary Research Communications;2024-08-14

2. Buffering the Heart Against Atrial Fibrillation;Circulation;2024-08-13

3. Case report: A 56-year-old woman presenting with torsades de pointes and cardiac arrest associated with levosimendan administration and underlying congenital long QT syndrome type 1;Heliyon;2024-04

4. Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future;Frontiers in Cardiovascular Medicine;2024-03-19

5. Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta‐analysis;ESC Heart Failure;2024-02-28